Citius Oncology, Inc. CTOR Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s common stock, par value (in dollars per share)?
- Citius Oncology, Inc. (CTOR) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Citius Oncology, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Citius Oncology, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Citius Oncology, Inc.'s common stock, par value (in dollars per share)?
- Over 3 years (2022 to 2025), Citius Oncology, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.